4732:TSEUSS Co., Ltd. Analysis

At TWD 16.85, NatureWise Biotech & Medicals Corporation shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 3.8%. RSI sits at 51.9, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near TWD 15.25 and resistance around TWD 16.75.
Revenue is contracting at 3.8% on a -52.2% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 37.2%, a beta of -0.20 and a maximum drawdown of 36.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.